Antibiotic Potentiation by Targeting of a Signal Transduction System
Antibiotic Potentiation by Targeting of a Signal Transduction System
批准号:
8703981
负责人:
SUSAN BOYLE-VAVRA
金额:
$21.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-03-01 至 2016-02-29
关键词:
Animal ModelAntibiotic ResistanceAntibioticsBacterial Drug ResistanceBindingBiological AssayBiosensorCell WallCellsChemicalsChemosensitizationClinicalCommunicable DiseasesCommunitiesDNA BindingDaptomycinDevelopmentDimerizationElectrostaticsEpidemicGene ClusterGeneticHalf-LifeHealthcareHospitalizationHumanIn VitroInfectionInfectious Skin DiseasesInterruptionLactamsLeadLifeLigandsLuc GeneLungMetabolicMethicillinMinorModelingMonobactamsMusMutagenesisOperonOxacillinParasitesPathway interactionsPeptidesPhasePhenotypePhosphorylationProtein BindingProteinsResistanceReverse Transcriptase Polymerase Chain ReactionRodent ModelSerum ProteinsShapesSignal TransductionSkinStaphylococcus aureusStressStructureStructure-Activity RelationshipSurface Plasmon ResonanceTechniquesTestingToxic effectValidationVancomycinWorkantimicrobialantimicrobial drugbasecell growthcytotoxicitydesignefficacy testingimprovedin vitro testingin vivoinhibitor/antagonistkillingsmethicillin resistant Staphylococcus aureusnovel therapeuticspathogenpre-clinicalpromoterpublic health relevanceresistant strainscaffoldscreeningskin abscesssmall moleculevirtual
中文摘要
项目摘要/摘要
金黄色葡萄球菌是一种适应良好的人类寄生虫,既是共生的又是重要的病原体。
它导致多种传染病,从轻微的皮肤脓肿到严重的
需要住院治疗的感染和中毒。金黄色葡萄球菌对几乎所有的SS-内酰胺类耐药,即所谓的
耐甲氧西林金黄色葡萄球菌(MRSA)是医疗保健相关的主要原因,自20世纪90年代以来,
社区相关感染。耐甲氧西林金黄色葡萄球菌感染的流行增强了确定
成功治疗的替代抗菌剂。本申请涉及VRA操纵子
在S金黄色葡萄球菌菌株中保守,并编码一个三组分的信号转导系统
并对临床上重要的抗菌药引起的细胞壁压力做出反应。实验性地中断了
MRSA菌株中的VRA操纵子显著降低苯唑西林的最低抑菌浓度
耐甲氧西林金黄色葡萄球菌中的甲氧西林同系物。因此,我们希望探索VRA操纵子被小分子抑制的想法
分子可能会增强SS-内酰胺类抗生素,如苯唑西林,杀死MRSA菌株和
治疗由它们引起的感染。由于VRA操纵子表达是由许多细胞壁剂诱导的
化学类,我们确定的苯唑西林增效剂也可以增强多种其他
干扰细胞壁合成的抗菌剂,如万古霉素、阳离子多肽和达托霉素。
英文摘要
PROJECT SUMMARY/ABSTRACT
Staphylococcus aureus is a well-adapted human parasite that is both a commensal and an important pathogen.
It is responsible for a wide variety of infectious diseases that range from minor skin abscesses to severe
infections and toxinoses requiring hospitalization. S. aureus strains resistant to nearly all ss-lactams, so-called
methicillin-resistant S. aureus (MRSA), are a leading cause of healthcare associated and, since the 1990s,
community-associated infections. This epidemic of MRSA infections has enhanced the urgency to identify
alternative antimicrobial agents for successful treatment. The present application concerns the vra operon that
is conserved among S aureus strains and encodes a three-component signal transduction system that senses
and responds to cell-wall stress elicited by clinically important antimicrobials. Experimental interruption of the
vra operon in a MRSA strain dramatically decreases the minimal inhibitory concentration of oxacillin, a
methicillin congener, in MRSA strains. Thus, we wish to explore the idea that vra operon inhibition by small
molecules may enhance the ability of ss-lactam antibiotics, such as oxacillin, to kill MRSA strains and
treat infections caused by them. Since vra operon expression is induced by cell-wall agents from many
chemical classes, the oxacillin potentiators we identify may also enhance activity of a wide variety of other
antimicrobials that interfere with cell-wall synthesis such as vancomycin, cationic peptides and daptomycin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Signal Transduction in Resistance to Cell-Wall Antimicrobials in MRSA
-
批准号:8090590
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2010
-
负责人:SUSAN BOYLE-VAVRA
-
依托单位:
GLYCOPEPTIDE RESISTANCE LOCI IN STAPHYLOCOCCUS AUREUS
-
批准号:2833389
-
项目类别:
-
资助金额:$7.55万
-
财政年份:1999
-
负责人:SUSAN BOYLE-VAVRA
-
依托单位:
GLYCOPEPTIDE RESISTANCE LOCI IN STAPHYLOCOCCUS AUREUS
-
批准号:6171066
-
项目类别:
-
资助金额:$7.55万
-
财政年份:1999
-
负责人:SUSAN BOYLE-VAVRA
-
依托单位:
GLYCOPEPTIDE RESISTANCE LOCI IN STAPHYLOCOCCUS AUREUS
-
批准号:6374104
-
项目类别:
-
资助金额:$7.55万
-
财政年份:1999
-
负责人:SUSAN BOYLE-VAVRA
-
依托单位:
海外基金